Here are some facts.

African ancestry predisposes to higher prevalence of chronic kidney disease (CKD) compared to other racial and ethnic groups.

African ancestry makes you more likely to develop end-stage kidney disease (ESKD), requiring dialysis or kidney transplant.

African Americans have higher rates of high blood pressure and diabetes which are two major risk factors for CKD.

Kidney disease risk can be influenced by the presence of Apolipoprotein1 (APOL1) variants with other genetic and environmental exposures such as HIV infection.

Approximately 13% of African Americans carry the APOL1 variant gene. Afro-Caribbeans and Latinx are also more prone to carry the APOL1 variant gene.

A blood test (Renasight gene panel)to detect APOL1 gene variant is available for early detection of Mediated Kidney Disease (AMKD).

Renasight gene panel also can detect genetic basis for other causes of kidney disease.

We, at NY Kidney & Hypertension Medicine (NYKHM) are dedicated to bringing the latest medical innovations to our communities, so our patients with chronic kidney disease can take charge of their health and wellness.

Renasight gene panel test enables us and patients to understand kidney disease risk early, so we can take timely action and deliver the most effective care available today.